In the case of the adipocytes derived from subADMSCs, the plasmalemmal expression of CD36/SR-B2 seemed to be affected by both AS160 silencing (35% of data variability, p < 0.01) and metabolic syndrome (38% of data variability, p < 0.01, Figure 5A). The gene discussed is CD36; the disease is metabolic syndrome.